1. The initial core pathophysiologic defect of type 2 diabetes is:

2. Which of the following statements accurately describes the contribution of fasting plasma glucose (FPG) and postprandial glucose (PPG) on A1C?

3. Which of the following treatment goals is recommended by the American Diabetes Association?

4. Which of the following statements is correct regarding the risks of postprandial hyperglycemia?

5. Which of the following medications primarily targets PPG?

6. Which of the following medications lowers A1C by slowing the rate of carbohydrate absorption in the small intestine?

7. Which of the following medications that targets PPG has the lowest risk of hypoglycemia?

8. Mr. Parker is a 59-year-old obese man with type 2 diabetes for 12 years. He takes metformin 1000mg twice daily and insulin glargine 36 units subcutaneously once daily. His A1C today is 7.9%. He self-monitors his blood glucose levels in the morning before breakfast. His average FPG is 118 mg/dL. Which of the following plans is most reasonable?

« Return to Activity